Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	178.05M
Revenue (ttm)	277.68M
Net Income (ttm)	7.95M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	22.40
Forward PE	n/a
Dividend	0.03 (1.05%)
Ex-Dividend Date	May 17, 2024

Volume	4
Average Volume	411
Open	2.640
Previous Close	2.650
Day's Range	2.640 - 2.640
52-Week Range	1.864 - 2.634
Beta	0.92
RSI	52.00
Earnings Date	Feb 28, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,331
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2023, Laboratorio Reig Jofre's revenue was 317.95 million, an increase of 15.95% compared to the previous year's 274.21 million. Earnings were 9.41 million, an increase of 16.04%.

Financial numbers in EUR